-
Categories
health policy sites
health policy primers
HR 3590 "ObamaCare"
Tag Archives: FDA
The FDA, Avastin, and your life
Paul Hsieh, MD of Freedom and Individual Rights in Medicine writes: The Food and Drug Administration (FDA) is on the verge of taking the highly unusual step of “decertifying” the cancer drug Avastin that it had previously approved. In addition … Continue reading
FDA on your DNA: “You can’t handle the truth!”
From Paul Hsieh: Recent advances in biotechnology have allowed private companies to offer affordable genetic testing directly to consumers, to help them determine their risks of developing problems such as diabetes, heart disease, and various forms of cancer. In response, … Continue reading
Posted in Policy - National, PPC
Tagged choice, FDA, genetic testing, medical technology and innovation, nanny state
Leave a comment
FDA’s History Reveals Power Plays Produced No Health Benefits
So says a press release from the Independent Institute: Oakland, CA, Feb. 10, 2010—The Food and Drug Administration (FDA) has requested a $4.03 billion budget for FY2011, a 23 percent increase over last year. Prompted by the FDA’s vast reach … Continue reading
Reduce drug prices by reducing FDA’s authority
David R. Henderson and Charles L. Hooper have an excellent column in Forbes. An excerpt: Do you need a government agency to tell you which TV has a vivid picture? Do you need a government agency to tell you which … Continue reading
The FDA’s Big Bad Wolfe
Charles L. Hooper and David R. Henderson in Forbes: Since Barack Obama was elected, there has been much hopeful talk about addressing this country’s health care problems. Unfortunately, some of the ideas discussed have been bad ones and, therefore, will … Continue reading
Drug Approval Denationalization
Daniel Klein, economist at George Mason University, offers his answer to the Davos Question, saying that drugs approved in Canada, Britain, and other places gain automatic approval in the United States. The drug-approving agencies of recognized countries would become more … Continue reading
Would President Obama kill drug development?
He would, suggests Charles Hooper at Forbes.com. Some selections: Say a biotech company is developing a new drug for breast cancer. My consulting firm, Objective Insights, looks at the financial value of the project. If the expected value–probability-adjusted value–of the … Continue reading
Posted in prescription drugs
Tagged FDA, health care in England, medical technology and innovation
3 Comments
Shall the FDA ban peanuts?
Fox News, July 23: The Seattle Mariners are declaring two sections of Safeco Field no-peanut zones for a couple of games this summer. The AL club announced the move Wednesday to make the ballpark safer for children and grown-up fans … Continue reading